Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Medtronic
Argus Health
Harvard Business School
Daiichi Sankyo
Julphar
Express Scripts
Colorcon
Chinese Patent Office

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,697,125

« Back to Dashboard

Which drugs does patent 8,697,125 protect, and when does it expire?

Patent 8,697,125 protects NESINA and is included in one NDA.

This patent has eleven patent family members in ten countries.
Summary for Patent: 8,697,125
Title:Tablet preparation without causing a tableting trouble
Abstract: The present invention provides a tablet without causing a tableting trouble, which is superior in the tablet formability, dissolution property of pharmaceutically active ingredient, and the like.
Inventor(s): Ono; Akihiko (Osaka, JP), Marunaka; Shigeyuki (Osaka, JP), Fukuta; Makoto (Osaka, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:12/449,256
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Formulation; Use;

Drugs Protected by US Patent 8,697,125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Takeda Pharms Usa NESINA alogliptin benzoate TABLET;ORAL 022271-001 Jan 25, 2013 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Takeda Pharms Usa NESINA alogliptin benzoate TABLET;ORAL 022271-002 Jan 25, 2013 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Takeda Pharms Usa NESINA alogliptin benzoate TABLET;ORAL 022271-003 Jan 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,697,125

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2007-023584Feb 1, 2007
PCT Information
PCT FiledJanuary 30, 2008PCT Application Number:PCT/JP2008/051896
PCT Publication Date:August 07, 2008PCT Publication Number: WO2008/093878

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Queensland Health
AstraZeneca
Moodys
Johnson and Johnson
Fuji
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.